Swedish Cancer Institute-Eastside Oncology Hematology — Bellevue, Washington

Swedish Cancer Institute-Eastside Oncology Hematology is a clinical research site located in Bellevue, Washington, United States 98005.

Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

Swedish Cancer Institute-Eastside Oncology Hematology has participated in 38 clinical trials with 17 currently active.

Therapeutic areas: Choriocarcinoma, FIGO Stage I Gestational Trophoblastic Tumor, FIGO Stage II Gestational Trophoblastic Tumor.

Sponsors: GOG Foundation, National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology.

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Swedish Cancer Institute-Eastside Oncology Hematology?

Swedish Cancer Institute-Eastside Oncology Hematology has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Swedish Cancer Institute-Eastside Oncology Hematology conducted?

Swedish Cancer Institute-Eastside Oncology Hematology has 38 clinical trials on record, with 17 currently active. Their work covers Choriocarcinoma, FIGO Stage I Gestational Trophoblastic Tumor, FIGO Stage II Gestational Trophoblastic Tumor.

Is Swedish Cancer Institute-Eastside Oncology Hematology accredited by Crixeo Health?

Swedish Cancer Institute-Eastside Oncology Hematology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Swedish Cancer Institute-Eastside Oncology Hematology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.